• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Turns Lower; Crude Oil Rises Sharply

    8/11/22 2:47:18 PM ET
    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Oil & Gas Production
    Energy
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMPY alert in real time by email

    U.S. stocks pared gains toward the end of trading, with the Nasdaq Composite turning lower on Thursday.

    The Dow traded up 0.21% to 33,380.67 while the NASDAQ fell 0.46% to 12,795.35. The S&P also rose, gaining, 0.06% to 4,212.90.

    Also check this: Market Volatility Declines Sharply As Dow Jumps Over 500 Points


    Leading and Lagging Sectors


    Energy shares climbed 3.6% on Thursday. Meanwhile, top gainers in the sector included Exterran Corporation (NYSE:EXTN), up 10% and Amplify Energy Corp. (NYSE:AMPY) up 10%.


    In trading on Thursday, health care shares fell by 0.3%.


    Top Headline


    Producer prices dropped 0.5% month-over-month in July, following a revised 1% increase in the previous month and versus market expectations of a 0.2% rise. It is the first drop in the index in more than two years.


    Equities Trading UP


    Veru Inc (NASDAQ:VERU) shares shot up 38% to $16.21 after the company reported Q3 earnings results.


    Shares of FlexShopper, Inc. (NASDAQ:FPAY) got a boost, shooting 57% to $1.7552 after the company reported Q2 results.


    Direct Digital Holdings, Inc. (NASDAQ:DRCT) shares were also up, gaining 22% to $3.11 after the company reported better-than-expected Q2 EPS results.


    Equities Trading DOWN

    Athenex, Inc (NASDAQ:ATNX) shares tumbled 49% to $0.5645 after the company reported pricing of $30 million public offering of common stock and warrants.


    Shares of Sonos, Inc. (NASDAQ:SONO) were down 25% to $17.06 after the company reported worse-than-expected Q3 sales results and issued FY22 sales guidance below estimates.


    Seer, Inc. (NASDAQ:SEER) was down, falling 25% to $9.94 after JP Morgan downgraded the stock from Overweight to Neutral and lowered its price target from $20 to $12. Seer recently reported better-than-expected Q2 EPS and sales results.


    Also check out: Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday


    Commodities

    In commodity news, oil traded up 2.8% to $94.51, while gold traded down 0.4% to $1,806.30.


    Silver traded down 2.1% to $20.305 on Thursday while copper rose 1.4% to $3.7020.



    Euro zone


    European shares were mixed today. The eurozone’s STOXX 600 gained 0.06%, London’s FTSE 100 fell 0.55% while Spain’s IBEX 35 Index rose 0.33%. The German DAX fell 0.05%, French CAC 40 rose 0.33% and Italy’s FTSE MIB Index jumped 0.69%.

     

    Economics

     

    U.S. initial jobless claims rose by 14,000 to 262,000 the week that ended August 6th.


    Producer prices dropped 0.5% month-over-month in July, following a revised 1% increase in the previous month and versus market expectations of a 0.2% rise. It is the first drop in the index in more than two years.
    Check out this: Bitcoin Jumps Above $24,000 Again, Here Are Other Crypto Movers That Should Be On Your Radar Today


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 94,348,500 cases with around 1,060,750 deaths. India confirmed a total of at least 44,206,990 cases and 526,870 deaths, while France reported over 34,144,960 COVID-19 cases with 152,910 deaths. In total, there were at least 592,574,990 cases of COVID-19 worldwide with more than 6,446,510 deaths.

     

    Get the next $AMPY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMPY
    $ATNX
    $DRCT
    $EXTN

    CompanyDatePrice TargetRatingAnalyst
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Sonos Inc.
    $SONO
    11/6/2025$17.00Underweight → Equal-Weight
    Morgan Stanley
    Amplify Energy Corp.
    $AMPY
    6/30/2025$6.00Buy
    Alliance Global Partners
    Sonos Inc.
    $SONO
    9/26/2024$25.00 → $11.00Overweight → Underweight
    Morgan Stanley
    Sonos Inc.
    $SONO
    8/8/2024$25.00 → $10.00Buy → Hold
    Craig Hallum
    Veru Inc.
    $VERU
    5/14/2024$5.00Buy
    B. Riley Securities
    Amplify Energy Corp.
    $AMPY
    5/2/2024$11.00Buy
    The Benchmark Company
    Veru Inc.
    $VERU
    3/28/2024$3.00Outperform
    Raymond James
    More analyst ratings

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Coliseum Capital Management, Llc bought $11,556,296 worth of shares (733,073 units at $15.76) (SEC Form 4)

    4 - Sonos Inc (0001314727) (Issuer)

    2/6/26 7:05:20 PM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    PRESIDENT & CFO Horn David R. was granted 79,000 shares, increasing direct ownership by 18% to 509,005 units (SEC Form 4)

    4 - Seer, Inc. (0001726445) (Issuer)

    2/5/26 6:54:29 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    CEO AND CHAIR Farokhzad Omid was granted 697,162 shares, increasing direct ownership by 26% to 3,373,449 units (SEC Form 4)

    4 - Seer, Inc. (0001726445) (Issuer)

    2/5/26 6:52:23 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    SEC Filings

    View All

    Direct Digital Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Direct Digital Holdings, Inc. (0001880613) (Filer)

    2/12/26 1:33:20 PM ET
    $DRCT
    Advertising
    Consumer Discretionary

    SEC Form EFFECT filed by Direct Digital Holdings Inc.

    EFFECT - Direct Digital Holdings, Inc. (0001880613) (Filer)

    2/12/26 12:15:23 AM ET
    $DRCT
    Advertising
    Consumer Discretionary

    SEC Form S-8 filed by Direct Digital Holdings Inc.

    S-8 - Direct Digital Holdings, Inc. (0001880613) (Filer)

    2/11/26 5:27:36 PM ET
    $DRCT
    Advertising
    Consumer Discretionary

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Direct Digital Holdings Regains Compliance with Nasdaq Bid Price Requirement

    HOUSTON, Feb. 12, 2026 /PRNewswire/ -- Direct Digital Holdings, Inc. (NASDAQ:DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP") and Orange 142, LLC ("Orange 142"), today announced that the Company has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. Mark Walker, CEO of Direct Digital Holdings, commented, "Evide

    2/12/26 1:30:00 PM ET
    $DRCT
    Advertising
    Consumer Discretionary

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Orange 142 and Pigeon Forge Department of Tourism Detail Early Case Study on AI-Driven Search

    New webinar breaks down one of the industry's first tested geo frameworks for AI search AUSTIN, Texas and PIGEON FORGE, Tenn., Feb. 10, 2026 /PRNewswire/ -- Orange 142, LLC ("Orange 142"), a division of Direct Digital Holdings (NASDAQ:DRCT) and a leading digital marketing agency for mid-market brands and agencies, in partnership with the 4As and the Pigeon Forge Department of Tourism, today announced an upcoming webinar on how a leading travel destination adapted its digital strategy to remain visible as consumer discovery shifts toward AI-driven search. Titled How to Get Your Brand Recommended by AI: A Pigeon Forge Case Study, the webinar will outline a practical, tested approach to Generat

    2/10/26 3:36:00 PM ET
    $DRCT
    Advertising
    Consumer Discretionary

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Veru with a new price target

    Canaccord Genuity initiated coverage of Veru with a rating of Buy and set a new price target of $25.00

    12/18/25 9:11:57 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sonos upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Sonos from Underweight to Equal-Weight and set a new price target of $17.00

    11/6/25 8:42:37 AM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    Alliance Global Partners resumed coverage on Amplify Energy with a new price target

    Alliance Global Partners resumed coverage of Amplify Energy with a rating of Buy and set a new price target of $6.00

    6/30/25 7:57:58 AM ET
    $AMPY
    Oil & Gas Production
    Energy

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KLISYRI

    Submission status for ATHENEX INC's drug KLISYRI (ORIG-1) with active ingredient TIRBANIBULIN has changed to 'Approval' on 12/14/2020. Application Category: NDA, Application Number: 213189, Application Classification: Type 1 - New Molecular Entity

    12/20/20 4:30:55 PM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Coliseum Capital Management, Llc bought $11,556,296 worth of shares (733,073 units at $15.76) (SEC Form 4)

    4 - Sonos Inc (0001314727) (Issuer)

    2/6/26 7:05:20 PM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    Chief Executive Officer Conrad Thomas bought $1,008,045 worth of shares (62,325 units at $16.17), increasing direct ownership by 26% to 305,103 units (SEC Form 4)

    4 - Sonos Inc (0001314727) (Issuer)

    11/18/25 9:00:31 AM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    Director Coghill Clint D bought $1,335,989 worth of shares (350,000 units at $3.82) (SEC Form 4)

    4 - Amplify Energy Corp. (0001533924) (Issuer)

    8/14/25 8:01:01 PM ET
    $AMPY
    Oil & Gas Production
    Energy

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Financials

    Live finance-specific insights

    View All

    Direct Digital Holdings Regains Compliance with Nasdaq Bid Price Requirement

    HOUSTON, Feb. 12, 2026 /PRNewswire/ -- Direct Digital Holdings, Inc. (NASDAQ:DRCT) ("Direct Digital Holdings" or the "Company"), a leading advertising and marketing technology platform operating through its companies Colossus Media, LLC ("Colossus SSP") and Orange 142, LLC ("Orange 142"), today announced that the Company has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share, and otherwise satisfies all applicable criteria for continued listing on The Nasdaq Capital Market. Mark Walker, CEO of Direct Digital Holdings, commented, "Evide

    2/12/26 1:30:00 PM ET
    $DRCT
    Advertising
    Consumer Discretionary

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the fourth quarter and full year 2025 on Thursday, February 26, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer's website at investor.seer.bio. An archived replay will be available on the company's website following the event. About SeerSeer is a life sciences company developing transformative products that open a new gateway to th

    2/5/26 4:05:00 PM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Leadership Updates

    Live Leadership Updates

    View All

    Sonos Appoints Carmine Arabia, Mandy Fields and Joe Kennedy to Board of Directors

    Sonos, Inc. (NASDAQ:SONO) today announced the appointment of Carmine Arabia, Mandy Fields and Joe Kennedy to its Board of Directors. The additions strengthen the Board with deep operating, financial, and technology platform expertise as Sonos enters its next phase of growth. "These three leaders bring impressive and highly complementary experience, as Sonos focuses on delighting customers and building durable, long-term value for shareholders," said Julius Genachowski, Chair of the Sonos Board of Directors. "Carmine has unmatched experience scaling complex global hardware platforms. Mandy adds rigorous financial leadership shaped by helping build a culturally resonant consumer brand. Joe

    1/12/26 4:05:00 PM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    Seer Appoints Isaac Ro to its Board of Directors

    REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced it has appointed Isaac Ro to serve on its Board of Directors. "We are excited to welcome Isaac to our board," said Omid Farokhzad, Chair and CEO of Seer. "Isaac brings a rare combination of financial leadership and deep sector experience across life science tools, diagnostics, and the broader healthcare ecosystem. His proven track record of guiding companies through transformative growth will be invaluable as we continue to execute on key milestones and accelerate the impact of our platform." "I'm looking forward to work

    9/2/25 7:00:00 AM ET
    $SEER
    $WGS
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Retail: Computer Software & Peripheral Equipment
    Technology

    Amplify Energy Announces Strategic Update and CEO Transition

    HOUSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE:AMPY) ("Amplify," the "Company," "us," or "our") today announced an update on strategic initiatives and changes to the executive leadership team. Strategic Initiatives Amplify is committed to simplifying its portfolio, focusing capital and management resources on the most attractive investment opportunities, and creating value for shareholders. Amplify intends to become more oil-weighted, reduce debt, lower operating costs, and streamline the organization. To accomplish the goals above, Amplify is undertaking several initiatives. First, Amplify recently engaged TenOaks Energy Advisors to explore market int

    7/22/25 6:00:00 AM ET
    $AMPY
    Oil & Gas Production
    Energy

    $AMPY
    $ATNX
    $DRCT
    $EXTN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Direct Digital Holdings Inc.

    SC 13D/A - Direct Digital Holdings, Inc. (0001880613) (Subject)

    11/22/24 4:11:23 PM ET
    $DRCT
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Sonos Inc.

    SC 13G/A - Sonos Inc (0001314727) (Subject)

    11/14/24 6:05:25 AM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Veru Inc.

    SC 13G/A - VERU INC. (0000863894) (Subject)

    11/12/24 9:34:37 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care